Form D · Biotechnology
ISTO TECHNOLOGIES INC
Olivette, MO · CIK 0001052380
Offering snapshot reported Jan 6, 2015 · SEC filing
- Reported sold
- $2.46M Offering amount: $4.5M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 6, 2015 | Initial | $2,460,082 | No comparison | 8 | SEC filing |
| Mar 17, 2014 | Initial | $8,000,000 | No comparison | 1 | SEC filing |
| Jun 19, 2013 | Initial | $2,009,365 | No comparison | 25 | SEC filing |
| Dec 10, 2009 | Initial | $3,272,961 | No comparison | 24 | SEC filing |
| May 8, 2009 | Initial | $5,404,890 | No comparison | Not reported | SEC filing |
| Jun 5, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 27, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-231522
Source: Form D, filed Jan 6, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Alafi, Ph.D. | Director |
| Cheryl R. Blanchard | Director |
| Tara Butler | Director |
| George Dunbar | Director, Executive |
| George W. Dunbar Jr. | Director, Executive |
| Joseph Feder | Director |
| Joseph Feder, Ph.D. | Director |
| Garry Gage | Executive |
| Gary Gage | Executive |
| Scott Gill | Executive |
| John E. Hart | Executive |
| Matthew I. Hermann | Director |
| Dean Kappel | Director |
| Martijn Kleljwegt | Director |
| William J. Maloney, M.D. | Director |
| William J. Maloney, M.Dl | Director |
| J. Alexander Marchosky | Director |
| James Mc Gorry | Director |
| Thomas Melzer | Director |
| Blake Miles | Executive |
| Mitchell Seyedin, Ph.D. | Director |
| James M. Stolze | Director |
| Penny White | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1155 Olivette Executive Office Parkway Suite 200
Olivette, MO, 63132
Olivette, MO, 63132